Active
SME

Speciality Medicines Ltd

Speciality Medicines Ltd IPO opened on 20 Mar 2026 and closed on 24 Mar 2026, with a price band of ₹117–₹124 per share. The IPO had a lot size of 1000 shares, requiring a minimum investment of ₹2,48,000 per lot at the upper price band. The issue size was ₹29.14 crore, and the shares get listed on 30 Mar 2026.

Speciality Medicines Ltd IPO Details

Listing Date

30 Mar 2026

Bid Price

₹117 - ₹124

Lot Size

1000 Shares

Minimum Investment

₹2,48,000 / 2 Lots

Issue Size

₹29.14 Cr

Key Dates to Track

    Here are the important dates you need to know in order to participate in this IPO

tick

Offer Start Date

20th Mar

tick

Offer End Date

24th Mar

tick

Allotment Date

25th Mar

tick

Refund Initiation

27th Mar

tick

Demat Transfer

27th Mar

tick

Listing Date

30th Mar

About Speciality Medicines Ltd IPO

Incorporated in 2021, Speciality Medicines Limited is engaged in the marketing and distribution of finished formulations of speciality pharmaceuticals. Its product portfolio includes oral and injectable therapies used in the management of chronic and complex conditions. The company offers formulations across multiple dosage forms, including tablets, capsules, syrups, injections, inhalers, and ophthalmic solutions. Its operations are structured around two models: contract manufacturing of finished formulations for international markets and the marketing and distribution of sourced speciality pharmaceutical products across domestic and overseas regions.

 

The company has established a presence in international markets with products registered or under registration in countries such as Jordan, Ethiopia, Uganda, Peru, and Namibia. As of 28 February 2026, it had 7 products registered overseas and 54 products under the registration process across 5 countries. Its distribution network spans over 20 states in India and more than 35 countries globally. The company’s operational profile includes a diversified product range, international exposure, client relationships, and a management team with industry experience.

 

Speciality Medicines Ltd Shareholding Pattern

  Pre-Issue Post-Issue
Promoter Group 59.67% 43.26%
Public Group 40.33% 56.74%

Speciality Medicines Ltd IPO Reservation

QIB Shares Offered 44,000 (1.87%)
NII (HNI) Shares Offered 10,78,000 (45.87%)
Retail Shares Offered 10,78,000 (45.87%)
Anchor Investor Shares Offered 0 (0%)
Total Shares Offered 23,50,000
Total Shares With Anchor Investor 23,50,000

Speciality Medicines Ltd IPO Lot Size

Application Lots Shares Amount
Retail (Min) 2 2,000 ₹2,48,000
Retail (Max) 2 2,000 ₹2,48,000
S HNI (Min) 3 3,000 ₹3,72,000
S HNI (Max) 8 8,000 ₹9,92,000
B HNI (MIN) 9 9,000 ₹11,16,000

Speciality Medicines Ltd IPO registrar

Skyline Financial Services Pvt
Phone Number +91 11 4045 0193-97;
Email Id ipo@skylinerta.com
Website www.skylinerta.com

Speciality Medicines Ltd IPO Lead Manager

1. Unistone Capital Private Limited

Speciality Medicines Ltd Financial Information

March 31, 2025 March 31, 2024 March 31, 2023
Net Worth ₹30.42 Cr ₹15.06 Cr ₹5.87 Cr
Reserves and Surplus ₹23.98 Cr ₹9.95 Cr ₹2.05 Cr
Total Borrowing ₹5.05 Cr ₹2.86 Cr ₹3.64 Cr

Speciality Medicines Ltd IPO Subscription LIVE Status

Category No. of shares offered No. of shares bid Subscription (Times)
Qualified Institutional Buyers (QIBs) 21,000 20,21,000 96.24
Non Institutional Investors (NIIs) 12,39,000 21,94,000 1.77
Retail Individual Investors (RIIs) 10,90,000 9,22,000 0.85
Total 23,50,000 51,37,000 2.19

Strength of Speciality Medicines Ltd

  • A Supplier of Specialty pharmaceuticals.
  • Experienced Promoters and Management Team.
  • Diversified Business Operations and Revenue Base.
  • Scalable Business Model.
  • Quality Assurance.
  • Existing Client Relationship.
  • Well Established Systems and Procedures.
  • Diversified Global Presence.
  • Diverse product portfolio.
  • Long Standing Client Relationship.

Risks Involved

  • The company has certain outstanding litigation against it, an adverse outcome of which may adversely affect its business, reputation and results of operations.
  • The company is subject to strict technical specifications, quality requirements by its customers. The company failures to comply with the quality standards and technical specifications prescribed by such customers may lead to loss of business from such customers and could negatively impact its business, results of warranty claims.
  • The pharmaceutical market is subject to extensive regulation and failures to comply with the existing and future regulatory requirements in any pharmaceutical market could expose it to litigation or other liabilities, which could adversely affect its reputation, business, financial condition and results of operations.
  • The company limited operating history may make it challenging for investors to assess its future growth prospects and overall business performance since the company was incorporated on February 05, 2021, which makes it a relatively new entity with a short track record of business and financial activities.
  • The company business is working capital intensive. If its unable to borrow to meet the company working capital requirements, it may materially and adversely affect its business and results of operations.
  • The company has not yet placed orders in relation to the funding Capital Expenditure towards establishment of Research and Development (R&D) Center comprising Construction of Building and Lab equipment which is proposed to be financed from the Issue proceeds of the IPO. In the event of any delay in placing the orders, or in the event the vendors are not able to provide the building and equipment in a timely manner, or at all, may result in time and cost over-runs and its business, prospects and results of operations may be adversely affected. Its proposed Research and Development (R&D) Center plans are subject to the risk of unanticipated delays in implementation due to factors including delays in construction, obtaining regulatory approvals in timely manner and cost overruns.
  • Delay in registration of Products in multiple geographical locations across the world may affect its revenue generation and overall financial performance.
  • The company requires a number of approvals, licences, registrations and permits in the ordinary course of its business and any failures or delay in obtaining the same in a timely manner may adversely affect the company operations.
  • The products that the company commercialize may not perform as expected which could adversely affect its business, financial condition and results of operations.
  • The Company does not have any experience in Research and Development Activities and will be depending on professional staff to be appointed by the Company.
stock

Invest in IPOs with ease

Sign-in to invest with your demat account, or set up a new demat account for free

Industry Outlook of Speciality Medicines IPO

  • Speciality Medicines Ltd operates in the pharmaceutical distribution and export segment, focusing on the supply of speciality drugs, vaccines, and healthcare products across multiple geographies.

  • The company’s presence in manufacturing, wholesaling, and exporting positions it within the broader pharmaceutical supply chain, which is linked to global demand for specialised therapies.

  • Therapeutic focus areas such as oncology, antivirals, and critical care are associated with sustained demand due to the rising incidence of complex health conditions.

  • The Indian pharmaceutical sector, valued at around $50 billion in FY 2023–24 with export reach across over 200 countries, provides a broader operating environment for such businesses.

  • Export-oriented operations, including sourcing medicines from multiple countries and supplying globally, may influence revenue streams and geographic diversification.

  • Compliance with international quality standards and certifications (such as WHO-GMP and GDP) forms part of operational requirements in regulated markets.

  • Continued expansion in speciality pharmaceuticals, supported by global healthcare demand and supply chain integration, may influence the company’s operational trajectory. 

Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your IPO allotment status for Speciality Medicines IPO. 

Explore Other IPOs

  • Current IPOs
  • Upcoming IPOs
  • Closed IPOs
  • IPO Performance
  • All
  • MainBoard
  • SME
Mehul Telecom Limited IPO
Bidding Period
17th Apr 2026 - 4th Apr 2026
Price Range
₹96.0 - 98.0
IPO Size
₹27,73,00,000
Aarvee Engineering Consultants Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Aastha Spintex Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Absolute Project India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
AceVector Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Adroit Industries India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advanced SysTek Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advanta Enterprises Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advit Jewels Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Aggcon Equipments International Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Agilus Diagnostics Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Airox Technologies Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Ajay Poly Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Alcobrew Distilleries India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Allchem Lifescience Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Allied Engineering Works Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Alpine Texworld Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Annu Projects Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
AOne Steels India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
APPL Containers Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
NO ACTIVE IPO HERE
  • All
  • MainBoard
  • SME
EMIAC TECHNOLOGIES LIMITED IPO
Bidding Period
27th Mar 2026 - 4th Apr 2026
Price Range
₹93.0 - 98.0
IPO Size
₹32,00,00,000
SAFETY CONTROLS AND DEVICES LIMITED IPO
Bidding Period
6th Apr 2026 - 4th Apr 2026
Price Range
₹75.0 - 80.0
IPO Size
₹48,00,00,000
VIVID ELECTROMECH LIMITED IPO
Bidding Period
25th Mar 2026 - 3rd Mar 2026
Price Range
₹528.0 - 555.0
IPO Size
₹1,31,00,00,000
SAI PARENTERAL'S LIMITED IPO
Bidding Period
24th Mar 2026 - 3rd Mar 2026
Price Range
₹372.0 - 392.0
IPO Size
₹4,09,00,00,000
AMIR CHAND JAGDISH KUMAR EXPORTS LIMITED IPO
Bidding Period
24th Mar 2026 - 3rd Mar 2026
Price Range
₹201.0 - 212.0
IPO Size
₹4,40,00,00,000
HIGHNESS MICROELECTRONICS LIMITED IPO
Bidding Period
24th Mar 2026 - 3rd Mar 2026
Price Range
₹114.0 - 120.0
IPO Size
₹22,00,00,000
POWERICA LIMITED IPO
Bidding Period
24th Mar 2026 - 3rd Mar 2026
Price Range
₹375.0 - 395.0
IPO Size
₹11,00,00,00,000
TIPCO ENGINEERING INDIA LIMITED IPO
Bidding Period
23rd Mar 2026 - 3rd Mar 2026
Price Range
₹84.0 - 89.0
IPO Size
₹61,00,00,000
SPECIALITY MEDICINES LIMITED IPO
Bidding Period
20th Mar 2026 - 3rd Mar 2026
Price Range
₹117.0 - 124.0
IPO Size
₹29,00,00,000
CENTRAL MINE PLANNING AND DESIGN INSTITUTE LIMITED IPO
Bidding Period
20th Mar 2026 - 3rd Mar 2026
Price Range
₹163.0 - 172.0
IPO Size
₹18,42,00,00,000
NOVUS LOYALTY LIMITED IPO
Bidding Period
17th Mar 2026 - 3rd Mar 2026
Price Range
₹139.0 - 146.0
IPO Size
₹60,00,00,000
GSP CROP SCIENCE LIMITED IPO
Bidding Period
16th Mar 2026 - 3rd Mar 2026
Price Range
₹304.0 - 320.0
IPO Size
₹4,00,00,00,000
INNOVISION LIMITED IPO
Bidding Period
10th Mar 2026 - 3rd Mar 2026
Price Range
₹494.0 - 519.0
IPO Size
₹3,06,00,00,000
RAAJMARG INFRA INVESTMENT TRUST IPO
Bidding Period
11th Mar 2026 - 3rd Mar 2026
Price Range
₹99.0 - 100.0
IPO Size
₹60,00,00,00,000
APSIS AEROCOM LIMITED IPO
Bidding Period
11th Mar 2026 - 3rd Mar 2026
Price Range
₹104.0 - 110.0
IPO Size
₹36,00,00,000
RAJPUTANA STAINLESS LIMITED IPO
Bidding Period
9th Mar 2026 - 3rd Mar 2026
Price Range
₹116.0 - 122.0
IPO Size
₹2,55,00,00,000
SRINIBAS PRADHAN CONSTRUCTIONS LIMITED IPO
Bidding Period
6th Mar 2026 - 3rd Mar 2026
Price Range
₹91.0 - 98.0
IPO Size
₹20,00,00,000
ELFIN AGRO INDIA LIMITED IPO
Bidding Period
5th Mar 2026 - 3rd Mar 2026
Price Range
₹47.0 - 47.0
IPO Size
₹25,00,00,000
SEDEMAC MECHATRONICS LIMITED IPO
Bidding Period
4th Mar 2026 - 3rd Mar 2026
Price Range
₹1287.0 - 1352.0
IPO Size
₹10,87,00,00,000
ACETECH ECOMMERCE LIMITED IPO
Bidding Period
27th Feb 2026 - 3rd Mar 2026
Price Range
₹106.0 - 112.0
IPO Size
₹49,00,00,000
  • All
  • MainBoard
  • SME
GSP CROP SCIENCE LIMITED IPO
Issue Prize
320.00
Listing Day Close
356.10(11.25%)
INNOVISION LIMITED IPO
Issue Prize
519.00
Listing Day Close
372.80(-28.13%)
RAAJMARG INFRA INVESTMENT TRUST IPO
Issue Prize
100.00
Listing Day Close
106.83(7.00%)
APSIS AEROCOM LIMITED IPO
Issue Prize
110.00
Listing Day Close
160.65(46.36%)
RAJPUTANA STAINLESS LIMITED IPO
Issue Prize
122.00
Listing Day Close
112.90(-7.38%)
SRINIBAS PRADHAN CONSTRUCTIONS LIMITED IPO
Issue Prize
98.00
Listing Day Close
104.40(6.12%)
ELFIN AGRO INDIA LIMITED IPO
Issue Prize
47.00
Listing Day Close
47.60(2.13%)
SEDEMAC MECHATRONICS LIMITED IPO
Issue Prize
1352.00
Listing Day Close
1452.10(7.40%)
ACETECH ECOMMERCE LIMITED IPO
Issue Prize
112.00
Listing Day Close
117.60(5.36%)
STRIDERS IMPEX LIMITED IPO
Issue Prize
72.00
Listing Day Close
66.50(-6.94%)
OMNITECH ENGINEERING LIMITED IPO
Issue Prize
227.00
Listing Day Close
205.15(-9.69%)
YAAP DIGITAL LIMITED IPO
Issue Prize
145.00
Listing Day Close
133.35(-8.28%)
PNGS REVA DIAMOND JEWELLERY LIMITED IPO
Issue Prize
386.00
Listing Day Close
413.95(7.25%)
SHREE RAM TWISTEX LIMITED IPO
Issue Prize
104.00
Listing Day Close
73.45(-29.81%)
CLEAN MAX ENVIRO ENERGY SOLUTIONS LIMITED IPO
Issue Prize
1053.00
Listing Day Close
867.90(-17.57%)
MOBILISE APP LAB LIMITED IPO
Issue Prize
80.00
Listing Day Close
67.30(-16.25%)
KIAASA RETAIL LIMITED IPO
Issue Prize
127.00
Listing Day Close
116.85(-7.87%)
ACCORD TRANSFORMER AND SWITCHGEAR LIMITED IPO
Issue Prize
46.00
Listing Day Close
52.50(15.22%)
GAUDIUM IVF AND WOMEN HEALTH LIMITED IPO
Issue Prize
79.00
Listing Day Close
80.48(1.27%)
MANILAM INDUSTRIES INDIA LIMITED IPO
Issue Prize
69.00
Listing Day Close
52.45(-24.64%)

Frequently Asked Questions

What is Speciality Medicines Ltd IPO?

Answer Field

Speciality Medicines Ltd IPO is a SME IPO of 23,50,000 equity shares of a face value of ₹10 aggregating up to ₹29.14 Crores. The issue is priced at ₹117 to ₹124 per share. The minimum order quantity is 1000 Shares. The IPO opens on March 20, 2026, and closes on March 24, 2026. Skyline Financial Services Pvt is the registrar for the IPO. The shares are proposed to be listed on BSE-SME.

When Speciality Medicines Ltd IPO will open?

Answer Field

The Speciality Medicines Ltd IPO opens on March 20, 2026 and closes on March 24, 2026.

What is the lot size of Speciality Medicines Ltd?

Answer Field

Speciality Medicines Ltd lot size is 1000 shares, and the minimum amount required is ₹2,48,000.

How to apply for Speciality Medicines Ltd IPO?

Answer Field

You can apply in Speciality Medicines Ltd IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

• Login to Bajaj Broking account App/Website & click on IPO

• Enter the number of lots and price at which you wish to apply.

• Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

• You will receive a mandate notification to block funds in your UPI app.

• Approve the mandate request on your UPI and funds will be blocked.

When is Speciality Medicines Ltd IPO allotment?

Answer Field

The finalization of Basis of Allotment for Speciality Medicines Ltd IPO will be done on March 25, 2026, and the allotted shares will be credited to your demat account by March 27, 2026.

When is Speciality Medicines Ltd IPO listing date?

Answer Field

The Speciality Medicines Ltd listing date is March 30, 2026.

Who is the registrar of Speciality Medicines Ltd IPO?

Answer Field

The registrar of Speciality Medicines Ltd IPO is Skyline Financial Services Pvt

Which company is the book-running lead manager of the IPO?

Answer Field

Unistone Capital Private Limited will be the book-running lead manager of this IPO.

What is the fresh issue of Speciality Medicines Ltd IPO?

Answer Field

The fresh issue size is ₹29.14 Crores equity shares.

What minimum lot size can retail subscribers subscribe to Speciality Medicines Ltd?

Answer Field

Retail investors can subscribe to a minimum of one lot, 1000 shares and ₹2,48,000 amount.

How can I approve the UPI mandate request for Speciality Medicines Ltd IPO?

Answer Field

To apply for Speciality Medicines Ltd IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Speciality Medicines Ltd?

Answer Field

The price of each Speciality Medicines Ltd share will be ranging in between ₹117 to ₹124 per share.

What is the cut-off time for the UPI mandate for Speciality Medicines Ltd IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, March 24, 2026.

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|